Diagnosing isolated cardiac sarcoidosis.

Cardiac sarcoidosis can occur without visible signs in other organs, making diagnosis difficult. Current diagnostic methods often miss the condition due to limited sensitivity. Prior research has shown that endomyocardial biopsy fails to detect sarcoidosis in many cases. This gap motivated a closer look at how repeated and guided biopsies might improve detection. No prior work had resolved the diagnostic challenges of isolated cardiac sarcoidosis. The problem remains that many patients go undiagnosed after a single biopsy. This uncertainty drove a retrospective analysis of biopsy outcomes in suspected cases. The goal was to assess diagnostic success rates and identify effective strategies.

The aim was to evaluate the effectiveness of repeated and imaging-guided biopsies in diagnosing isolated cardiac sarcoidosis. The specific problem is that many patients with cardiac sarcoidosis remain undiagnosed after a single biopsy. The motivation stems from the limitations of current diagnostic tools in detecting sarcoidosis confined to the heart. This study sought to determine how often a diagnosis is missed and how it can be improved. The researchers focused on patients with no extracardiac disease signs. They reviewed records of 74 patients with confirmed or probable sarcoidosis. The study aimed to track biopsy success rates across multiple attempts. The findings may suggest better approaches for diagnosing isolated cardiac sarcoidosis.

The researchers conducted a retrospective analysis of patient records from 2000 to 2010. They included 74 patients with histologically confirmed or clinically probable sarcoidosis. Medical records, lab results, imaging, and pathology reports were reviewed. Patients were divided into those with isolated cardiac sarcoidosis and others with extracardiac disease. Biopsy data were categorized by the number of attempts and diagnostic success. Imaging-guided techniques were used in some cases to target specific areas. The study tracked how many patients received a diagnosis on first, second, or third biopsy. The researchers also examined outcomes for patients who had cardiac transplants or were diagnosed postmortem.

The first biopsy diagnosed sarcoidosis in 10 of 31 patients with isolated cardiac sarcoidosis. Seven more patients were diagnosed after repeated biopsies guided by imaging. Eleven patients were diagnosed through mediastinal lymph node sampling. The first biopsy provided a diagnosis in 34% of cases. The second biopsy diagnosed 31%, and the third diagnosed 22%. Four patients were diagnosed after cardiac transplantation. One case was identified at autopsy following sudden cardiac death. The overall success rate increased with multiple biopsies. However, false negatives remained a challenge in patients with no extracardiac disease signs.

The authors suggest that isolated cardiac sarcoidosis remains undiagnosed in many cases after a single biopsy. Repeated and imaging-guided biopsies may improve detection rates. The study found that 66% of patients with isolated sarcoidosis remained undiagnosed after one biopsy. The success rate increased with additional attempts. The researchers propose that diagnostic strategies should include multiple biopsies. They emphasize the importance of imaging guidance in targeting biopsy sites. The findings may suggest that current diagnostic approaches are insufficient for isolated cases. The authors highlight the need for improved methods to detect sarcoidosis confined to the heart.